0.5900
-0.0200
(-3.28%)
At close: January 10 at 3:27:34 PM EST
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-23,475.9590
-24,126.1280
-23,744.8600
-12,484.3760
-7,750.1880
Investing Cash Flow
-756.8010
-681.8010
--
--
--
Financing Cash Flow
16,379.1780
4,418.9260
3,954.3000
-3,742.6570
64,997.6240
End Cash Position
5,792.2650
862.0890
21,251.0920
41,041.6520
57,268.6850
Capital Expenditure
--
-456.8010
--
--
--
Issuance of Capital Stock
16,085.9270
4,418.9260
4,000.0000
--
51,622.3370
Issuance of Debt
--
--
--
--
215.7100
Repayment of Debt
--
--
--
--
-546.1080
Repurchase of Capital Stock
--
--
-47.2940
-10,171.7320
--
Free Cash Flow
-23,932.7600
-24,582.9290
-23,744.8600
-12,484.3760
-7,750.1880
7/31/2021 - 8/13/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
COV.V Covalon Technologies Ltd.
3.2000
+3.23%
BLAB.CN Britannia Life Sciences Inc.
0.0850
0.00%
VXL.V Vaxil Bio Ltd.
0.0100
0.00%
HEM.V Hemostemix Inc.
0.2400
+20.00%
SVA.TO Sernova Corp.
0.2250
0.00%
EPRX.TO Eupraxia Pharmaceuticals Inc.
4.3200
-0.23%
CHGX.CN ChitogenX Inc.
0.0250
+66.67%